Earlier, multinational pharmaceutical giant Eli Lilly revealed an antibody “cocktail” that reportedly helps to significantly ease severe symptoms caused by COVID-19. One of its components, bamlanivimab, has already been approved for emergency use.
Earlier, multinational pharmaceutical giant Eli Lilly revealed an antibody “cocktail” that reportedly helps to significantly ease severe symptoms caused by COVID-19. One of its components, bamlanivimab, has already been approved for emergency use.
